These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9777370)

  • 1. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
    Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
    Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
    Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
    Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.
    Honegger AM; Dull TJ; Felder S; Van Obberghen E; Bellot F; Szapary D; Schmidt A; Ullrich A; Schlessinger J
    Cell; 1987 Oct; 51(2):199-209. PubMed ID: 3499230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.
    Barbieri MA; Roberts RL; Gumusboga A; Highfield H; Alvarez-Dominguez C; Wells A; Stahl PD
    J Cell Biol; 2000 Oct; 151(3):539-50. PubMed ID: 11062256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor.
    Heisermann GJ; Wiley HS; Walsh BJ; Ingraham HA; Fiol CJ; Gill GN
    J Biol Chem; 1990 Aug; 265(22):12820-7. PubMed ID: 2115882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation.
    Bertics PJ; Chen WS; Hubler L; Lazar CS; Rosenfeld MG; Gill GN
    J Biol Chem; 1988 Mar; 263(8):3610-7. PubMed ID: 3346210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.
    Lax I; Bellot F; Honegger AM; Schmidt A; Ullrich A; Givol D; Schlessinger J
    Cell Regul; 1990 Jan; 1(2):173-88. PubMed ID: 2100196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.
    Felder S; LaVin J; Ullrich A; Schlessinger J
    J Cell Biol; 1992 Apr; 117(1):203-12. PubMed ID: 1556153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.
    Morrison P; Takishima K; Rosner MR
    J Biol Chem; 1993 Jul; 268(21):15536-43. PubMed ID: 8393447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.
    Glenney JR; Chen WS; Lazar CS; Walton GM; Zokas LM; Rosenfeld MG; Gill GN
    Cell; 1988 Mar; 52(5):675-84. PubMed ID: 2449972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.
    Prywes R; Livneh E; Ullrich A; Schlessinger J
    EMBO J; 1986 Sep; 5(9):2179-90. PubMed ID: 3490969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions.
    Livneh E; Reiss N; Berent E; Ullrich A; Schlessinger J
    EMBO J; 1987 Sep; 6(9):2669-76. PubMed ID: 2824188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors.
    Chang CP; Lazar CS; Walsh BJ; Komuro M; Collawn JF; Kuhn LA; Tainer JA; Trowbridge IS; Farquhar MG; Rosenfeld MG
    J Biol Chem; 1993 Sep; 268(26):19312-20. PubMed ID: 8396132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase.
    Lamaze C; Schmid SL
    J Cell Biol; 1995 Apr; 129(1):47-54. PubMed ID: 7698994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C.
    Vega QC; Cochet C; Filhol O; Chang CP; Rhee SG; Gill GN
    Mol Cell Biol; 1992 Jan; 12(1):128-35. PubMed ID: 1729595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
    Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS
    J Biol Chem; 1990 Nov; 265(33):20517-23. PubMed ID: 2173710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.
    Honegger AM; Szapary D; Schmidt A; Lyall R; Van Obberghen E; Dull TJ; Ullrich A; Schlessinger J
    Mol Cell Biol; 1987 Dec; 7(12):4568-71. PubMed ID: 3501826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.
    Kashles O; Szapary D; Bellot F; Ullrich A; Schlessinger J; Schmidt A
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9567-71. PubMed ID: 3264402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiloride directly inhibits growth factor receptor tyrosine kinase activity.
    Davis RJ; Czech MP
    J Biol Chem; 1985 Feb; 260(4):2543-51. PubMed ID: 2982824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.